FDA recently announced new safety requirements for DPD screening in cancer patients. Kristine Ashcraft, founder and CEO of ...
Hundreds of clinical pharmacogenomics (PGx) tests are currently available on the market in ... choose the appropriate genotyping technology and develop laboratory procedures for sample processing and ...
Findings from the nationwide survey suggest interest in PGx while highlighting areas for UK policymakers to pay attention to, ...
The program will use NalaGenetics' PGx test to screen leprosy patients for the HLA-B*13:01 allele, which has been linked with a serious hypersensitivity reaction.
HOUSTON, Feb. 19, 2025 /PRNewswire/ -- AccessDx Laboratory ... the seamless delivery of pharmacogenomic (PGx) risk assessments, advanced diagnostic test results, and ongoing PGx monitoring ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results